Federated Hermes’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-57
| Closed | -$485 | – | 2062 |
|
|
2024
Q2 | $485 | Buy |
+57
| New | +$485 | ﹤0.01% | 1974 |
|
|
2024
Q1 | – | Sell |
-19
| Closed | -$243 | – | 2033 |
|
|
2023
Q4 | $243 | Buy |
+19
| New | +$243 | ﹤0.01% | 2026 |
|
|
2023
Q1 | – | Sell |
-7
| Closed | -$558 | – | 2121 |
|
|
2022
Q4 | $558 | Buy |
+7
| New | +$558 | ﹤0.01% | 2081 |
|
|
2021
Q2 | – | Sell |
-2,179
| Closed | -$782K | – | 2202 |
|
|
2021
Q1 | $782K | Buy |
+2,179
| New | +$782K | ﹤0.01% | 1460 |
|
|
2020
Q3 | – | Sell |
-5,330
| Closed | -$1.94M | – | 2247 |
|
|
2020
Q2 | $1.94M | Sell |
5,330
-110,252
| -95% | -$40.2M | ﹤0.01% | 1003 |
|
|
2020
Q1 | $24.6M | Buy |
115,582
+24,203
| +26% | +$5.15M | 0.07% | 297 |
|
|
2019
Q4 | $37.6M | Buy |
91,379
+2,352
| +3% | +$968K | 0.08% | 264 |
|
|
2019
Q3 | $31.4M | Buy |
89,027
+47,887
| +116% | +$16.9M | 0.08% | 261 |
|
|
2019
Q2 | $20.7M | Buy |
41,140
+5,008
| +14% | +$2.52M | 0.05% | 341 |
|
|
2019
Q1 | $35.9M | Buy |
36,132
+11,648
| +48% | +$11.6M | 0.09% | 244 |
|
|
2018
Q4 | $21.3M | Buy |
24,484
+5,468
| +29% | +$4.75M | 0.06% | 305 |
|
|
2018
Q3 | $19.7M | Hold |
19,016
| – | – | 0.05% | 356 |
|
|
2018
Q2 | $17.5M | Sell |
19,016
-46
| -0.2% | -$42.3K | 0.05% | 288 |
|
|
2018
Q1 | $18.6M | Buy |
+19,062
| New | +$18.6M | 0.05% | 263 |
|